Solventum Earnings Preview: What to Expect

Solventum Corporation (SOLV), based in Maplewood, Minnesota, is a healthcare company that develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs. With a market cap of $12 billion,  the company’s broad portfolio of solutions leverages material and data science, clinical research, and digital capabilities. Solventum operates in separation and purification, health information, medical solutions, medical device component, and oral care market. The leading global healthcare company is expected to announce its fiscal first-quarter earnings for 2026 after the market closes on Tuesday, May 5.

Ahead of the event, analysts expect SOLV to report a profit of $1.35 per share on a diluted basis, up marginally from $1.34 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.